SCHEMBL7592864

SCHEMBL7592864

Cc1cc(C)cc(P(=O)(c2cc(C)cc(C)c2)c2ccc3c(c2-c2c(P(=O)(c4cc(C)cc(C)c4)c4cc(C)cc(C)c4)ccc4c2OCO4)OCO3)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO2 P16083 3/20 0.38
CYP19A1 P11511 2/20 0.37
ALDH1A1 P00352 3/20 0.34
HSP90AA1 P07900 2/20 0.34
HSP90AB1 P08238 2/20 0.34
CYP3A4 P08684 2/20 0.33
CYP2D6 P10635 2/20 0.33
CYP2C9 P11712 2/20 0.33
TSHR P16473 2/20 0.33
CYP2C19 P33261 2/20 0.33
NPC1 O15118 2/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
LMNA P02545 1/20 0.33
CYP1A2 P05177 1/20 0.33
HIF1A Q16665 1/20 0.33
GABRP O00591 1/20 0.33
GABRD O14764 1/20 0.33
GABRA1 P14867 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6319700 0.88 NPC1 (0.35) ALDH1A1TSHRNPC1MAPTRAB9A
SCHEMBL7594183 0.87 HSP90AA1 (0.37) NQO2CYP19A1ALDH1A1HSP90AA1HSP90AB1
SCHEMBL7596886 0.86 NQO2 (0.36) NQO2CYP19A1ALDH1A1TSHRNPC1
SCHEMBL7594464 0.82 NQO2 (0.36) NQO2CYP19A1TSHRNPC1MAPT
SCHEMBL7642818 0.82 ALDH1A1 (0.34) NQO2CYP19A1ALDH1A1HSP90AA1CYP3A4
SCHEMBL7592861 0.80 NPC1 (0.37) ALDH1A1CYP3A4CYP2D6CYP2C9TSHR
SCHEMBL7599038 0.78 NPC1 (0.37) ALDH1A1HSP90AA1HSP90AB1TSHRNPC1
SCHEMBL7594461 0.77 RAB9A (0.40) NQO2CYP19A1ALDH1A1NPC1MAPT
SCHEMBL7598402 0.77 ALDH1A1 (0.35) NQO2CYP19A1ALDH1A1HSP90AA1CYP3A4
SCHEMBL7645402 0.77 CYP19A1 (0.34) NQO2CYP19A1HSP90AA1NPC1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0850945-B1 Chiral diphosphine compound, intermediate for preparing the same, transition metal complex having the same diphosphine compound as ligand and asymmetric hydrogenation catalyst TAKASAGO PERFUMERY CO LTD (JP) 2002-11-27 EP disclosed
US-6472539-B1 BASIFICATION OF MONOMER WITH SUCH AS BUTYLLITHIUM THEN DIMERIZATION IN NONPOLAR SOLVENT CONTAINING SUSPENDED OXIDATIVE METAL SALT SUCH AS FERRIC CHLORIDE; HIGH YIELD; CHEMICAL INTERMEDIATE TO ASYMMETRIC SYNTHESIS CATALYST TAKASAGO INTERNATIONAL CORPORATION (JP) 2002-10-29 US disclosed
US-5872273-A LIGANDS FOR FORMING HYDROGENATION CATALYST COMPLEXES TAKASAGO INTERNATIONAL CORPORATION (JP) 1999-02-16 US disclosed
EP-0850945-A1 Chiral diphosphine compound, intermediate for preparing the same, transition metal complex having the same diphosphine compound as ligand and asymmetric hydrogenation catalyst Takasago International Corporation (JP) 1998-07-01 EP disclosed